National Health Investors Inc (NYSE:NHI) Expected to Post Earnings of $1.42 Per Share

Wall Street brokerages expect National Health Investors Inc (NYSE:NHI) to announce $1.42 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for National Health Investors’ earnings, with the lowest EPS estimate coming in at $1.39 and the highest estimate coming in at $1.45. National Health Investors reported earnings per share of $1.36 during the same quarter last year, which suggests a positive year over year growth rate of 4.4%. The company is scheduled to report its next quarterly earnings results on Thursday, August 13th.

On average, analysts expect that National Health Investors will report full year earnings of $5.59 per share for the current fiscal year, with EPS estimates ranging from $5.54 to $5.64. For the next year, analysts anticipate that the company will post earnings of $5.55 per share, with EPS estimates ranging from $5.35 to $5.70. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that follow National Health Investors.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, May 11th. The real estate investment trust reported $1.37 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.40 by ($0.03). The company had revenue of $83.08 million during the quarter, compared to the consensus estimate of $80.77 million. National Health Investors had a net margin of 57.16% and a return on equity of 12.62%. National Health Investors’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.31 EPS.

Several equities research analysts recently issued reports on the stock. SunTrust Banks cut their target price on shares of National Health Investors from $77.00 to $61.00 and set a “hold” rating for the company in a research note on Thursday, April 23rd. Wells Fargo & Co cut their target price on shares of National Health Investors from $82.00 to $51.00 and set an “equal weight” rating for the company in a research note on Thursday, March 26th. Berenberg Bank assumed coverage on shares of National Health Investors in a research note on Wednesday, February 5th. They issued a “buy” rating and a $94.00 target price for the company. Mizuho downgraded shares of National Health Investors from a “buy” rating to a “neutral” rating and cut their target price for the company from $60.00 to $55.00 in a research note on Friday. Finally, KeyCorp cut their target price on shares of National Health Investors from $43.00 to $40.00 and set an “underweight” rating for the company in a research note on Thursday, May 14th. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $67.57.

In related news, Director Robert T. Webb acquired 2,151 shares of the business’s stock in a transaction on Monday, March 16th. The stock was purchased at an average cost of $46.28 per share, for a total transaction of $99,548.28. Following the completion of the transaction, the director now directly owns 63,339 shares of the company’s stock, valued at approximately $2,931,328.92. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO D. Eric Mendelsohn sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $90.58, for a total transaction of $362,320.00. Following the sale, the chief executive officer now owns 44,256 shares of the company’s stock, valued at $4,008,708.48. The disclosure for this sale can be found here. Insiders have acquired 29,576 shares of company stock valued at $1,096,421 over the last 90 days. Company insiders own 5.74% of the company’s stock.

A number of hedge funds have recently modified their holdings of NHI. ERTS Wealth Advisors LLC acquired a new stake in National Health Investors during the fourth quarter worth approximately $25,000. Van ECK Associates Corp raised its position in shares of National Health Investors by 108.4% in the first quarter. Van ECK Associates Corp now owns 521 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 271 shares in the last quarter. Marshall Wace North America L.P. acquired a new stake in shares of National Health Investors in the first quarter valued at approximately $31,000. Samalin Investment Counsel LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at approximately $40,000. Finally, Duncker Streett & Co. Inc. acquired a new stake in shares of National Health Investors in the fourth quarter valued at approximately $46,000. Hedge funds and other institutional investors own 70.53% of the company’s stock.

Shares of NYSE NHI opened at $52.98 on Monday. The stock has a market capitalization of $2.41 billion, a price-to-earnings ratio of 9.71 and a beta of 0.85. The business has a 50-day moving average of $50.81 and a 200-day moving average of $71.49. The company has a debt-to-equity ratio of 1.03, a current ratio of 12.05 and a quick ratio of 12.05. National Health Investors has a fifty-two week low of $31.37 and a fifty-two week high of $91.12.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Story: What is the return on assets formula?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.